Ordered, That notwithstanding Senate Rule 7 or any other rule to the contrary, the Senate Bill relative to pharmaceutical access, costs and transparency (Senate, No. 771) (the committee on Ways and Means having recommended that the bill be amended by substituting a new draft, Senate, No. 2651) shall be placed in the Orders of the Day for a second reading on Thursday, February 10, 2022.
All amendments shall be filed electronically in the office of the Clerk of the Senate by 3:00 P.M. on Monday, February 7, 2022. All such amendments shall be second reading-amendments to the Senate Ways and Means new draft (Senate, No. 2651), but further amendments in the third degree to such amendments shall be in order. The Clerk shall further specify the procedure and format for filing all amendments, consistent with this order.
After the bill as amended is ordered to a third reading, it shall immediately be read a third time and the question shall then immediately be on passing it to be engrossed, and no amendments shall be in order at the third reading of the bill unless recommended by the committee on Bills in the Third Reading.
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.